Flu, cancer, HIV: after Covid success, what next for mRNA vaccines?

Simple item page
dc.contributor.authorDevlin, Hannah
dc.date.accessioned2021-11-03T03:51:07Z
dc.date.available2021-11-03T03:51:07Z
dc.date.issued2021-11-03
dc.descriptionpage 43en_US
dc.identifier.urihttp://hdl.handle.net/123456789/43199
dc.language.isoenen_US
dc.publisherThe Guardian Australiaen_US
dc.subjectVaccinationen_US
dc.subjectImmune systemen_US
dc.titleFlu, cancer, HIV: after Covid success, what next for mRNA vaccines?en_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
November 3, 2021 pg 43.pdf
Size:
154.75 KB
Format:
Adobe Portable Document Format
Description:
Flu, cancer, HIV: after Covid success, what next for mRNA vaccines?
Download

License bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Newspaper Clippings